TipRanks
Advertisement
Advertisement
AB Science granted U.S. patnet for masitinib in treatment of SCD
PremiumThe FlyAB Science granted U.S. patnet for masitinib in treatment of SCD
10M ago
AB Science Reports Key Developments and Financial Results
Premium
Company Announcements
AB Science Reports Key Developments and Financial Results
1y ago
AB Science Reports Reduced Deficit and Clinical Progress
Premium
Company Announcements
AB Science Reports Reduced Deficit and Clinical Progress
1y ago
AB Science announces publication of results for masitinib
PremiumThe FlyAB Science announces publication of results for masitinib
3y ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―